IVS Dosing Technology is the innovative and international specialist in the field of dosing technology. Commissioned by Huvepharma, producer of instant enzyme powders, IVS Dosing Technology developed a measuring unit that concentrated dry micro components converts it to a liquid form. Following is our R & D department continued with this development. During 2015, we presented the POWLI Victam: Powder to Liquid. This patented machine manufacturers can convert all kinds of products in powder form to a highly accurate liquid dosage. In the meantime, there are various machine variants have been developed for, among other enzymes, probiotics and anti-coccidiostats. Powli ac to add anti-coccidiostats to compound developed IVS Dosing Technology Powli the ac. This machine variant makes it possible to add up to six different anti-coccidiostats in the production process. The great advantage of the Powli ac is that these additives are dosed on a coater, instead of on the mixer and processed directly in the final product. Therefore there is no question of cross-contamination. Because the products as the last post-processing is to be metered, moreover, the rinsing of the entire production line unnecessary. Some advantages No cross-contamination in the production line No storing or handling of contaminated product needed very precise dosage of microcomponents Added product is always fresh Dosage from 100g possible Dosing 1 gram addition, the deployment of the POWLI leads to advantages for the operational management in the plant. There is no more storage of contaminated products, energy consumption drops and there is significantly less CO2 emissions. The POWLI is a stand-alone system and can be integrated relatively easily and is an investment that is guaranteed recouped within two years.
